Mucopolysaccharidoses (MPS) are a group of genetic disorders that affect our body’s ability to break down and recycle sugar molecules called glycosaminoglycans, or GAGs, leading to buildup and causing severe symptoms. Gene therapy targets the root cause of disease and therefore may offer hope for slowing or halting the progression of some MPS disorders. Learn more at www.asgct.org/education/mps.

The subtitling of these videos was funded in part by a donation from Pfizer, Inc.

свернуть